nach oben

Sports Medicine

Erschienen in:

01.04.2002 | Leading Article

Anabolic Steroids

A Review for the Clinician

verfasst von: Eric C. Kutscher, Brian C. Lund, Paul J. Perry

Erschienen in: Sports Medicine | Ausgabe 5/2002

Einloggen, um Zugang zu erhalten

Abstract

The number of athletes self-administering ergogenic pharmacological agents to increase their competitive edge continues to be a problem. Most athletes using anabolic steroids (AS) have acquired a crude pharmacological database regarding these drugs. Their opinions regarding steroids have been derived from their subjective experiences and anecdotal information. For this reason, traditional warnings regarding the lack of efficacy and potential dangers of steroid misuse are disregarded. A common widely held opinion among bodybuilders is that the anabolic steroid experts are the athletic gurus who for years have utilised themselves as the experimental participants and then dispensed their empirical findings. This review will address the common anabolic steroid misconceptions held by many of today’s athletes by providing an evaluation of the scientific literature related to AS in athletic performance.

Dawson RT. Drugs in sports: the role of the physician. J Endocrinol 2001; 170: 55–61PubMedCrossRef

Maharaj VR, Dookie T, Mohammed S, et al. Knowledge, attitudes and practices of anabolic steroid usage among gym users in Trinidad. West Indian Med J 2000; 49: 55–8PubMed

Blue JG, Lombardo JA. Steroids and steroid-like compounds. Clin Sports Med 1999; 18: 667–89PubMedCrossRef

Silver MD. Use of ergogenic aids by athletes. J Am Acad Orthop Surg 2001; 9: 61–70PubMed

Wood AJ. Androgens in men: uses and misuses. N Engl J Med 1996; 334: 707–14CrossRef

Yates WR, Perry PJ, Anderson KH. Illicit anabolic steroid use: a controlled personality study. Acta Psychiatr Scand 1990; 81: 548–50PubMedCrossRef

Blue Cross and Blue Shield Association. Health Competition Foundation National survey on performance enhancing drugs in sports. Blue Cross and Blue Shield Association [online]. Available from URL: http://www.bcbs.com [Accessed 2001 Jan 1]

Sullivan ML, Martinez CM, Gennis P, et al. The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis 1998; 41: 1–15PubMedCrossRef

Faigenbaum AD, Zaichkowsky LD, et al. Anabolic steroid use by male and female middle school students [abstract]. Pediatrics 1998; 101 (5): E6CrossRef

10.

Yesalis CE, Bahrke MS. Anabolic-androgenic steroids: current issues. Sports Med 1995; 19: 326–40PubMedCrossRef

11.

Buckley WE, Yesalis CE, Bennell DL. Astudy of anabolic steroid use at the secondary school level: recommendations for prevention. In: Yesalis CE, editor. Anabolic steroids in sport and exercise. Champaign (IL): Human Kinetics Publishing, 1993: 71–86

12.

Green GA, Uryasz FD, Petr TA, et al. NCAA study of substance use and misuse habits of college student-athletes. Clin J Sport Med 2001; 11: 51–6PubMedCrossRef

13.

Yesalis CE, Buckley WE, Anderson WA, et al. Athletes’ projections of anabolic steroid use. Clin Sports Med 1990; 2: 155–71

14.

Yesalis CE, Herrick R, Buckley W, et al. Self-reported use of anabolic-androgenic steroids by elite power lifters. Physician Sportmed 1988; 16: 91–100

15.

Tricker R, O’Neill M, Cook D. The incidence of anabolic steroid use among competitive body builders. J Drug Educ 1989; 19: 313–25PubMedCrossRef

16.

Verroken M. Ethical aspects and the prevalence of hormone abuse in sport. J Endocrinol 2001; 170: 9–54CrossRef

17.

Kadi F, Eriksson A, Holmer S, et al.Effects of anabolic steroids on the muscle cells of strength trained athletes. Med Sci Sports Exerc 1999; 31: 1528–34PubMedCrossRef

18.

Sheffield-Moore M. Androgens and the control of skeletal muscle protein synthesis. Ann Med 2000; 32: 181–6PubMedCrossRef

19.

Kadi F. Adaptation of human skeletal muscle to training and anabolic steroids. Acta Physiol Scand Suppl 2000; 646: 1–52PubMed

20.

Haupt HA, Rovere GD. Anabolic steroids: a review of the literature. Am J Sports Med 1984; 12: 469–84PubMedCrossRef

21.

Bhasin S, Storer TW, Berman N, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med 1996; 335: 1–7PubMedCrossRef

22.

Mayer M, Rosen F. Interaction of anabolic steroids with glucocorticoid receptor sites in rat muscle cytosol. Am J Physiol 1975; 229: 1381–6PubMed

23.

Rubinow DR, Schmidt PJ. Androgens, brain, and behavior. Am J Psychiatry 1996; 153: 974–84PubMed

24.

Lamb DR. Anabolic steroids in athletics: how well do they work and how dangerous are they? Am J Sports Med 1984; 12: 31–8PubMedCrossRef

25.

Ariel G, Saville W. Anabolic steroids: the physiological effects of placebos. Med Sci Sports 1972; 4: 124–6

26.

Crist DM, Stackpole PJ, Peale GT. Effects of androgenic-anabolic steroids on neuromuscular power and body composition. J Appl Physiol 1983; 54: 366–70PubMedCrossRef

27.

Hickson RC, Ball KL, Falduto MT. Adverse effects of anabolic steroids. Med Toxicol Adverse Drug Exp 1989; 4: 254–71PubMedCrossRef

28.

Freed DL, Banks AJ, Longson D, et al. Anabolic steroids in athletics: crossover double-blind trial on weightlifters. BMJ 1975; 2: 471–3PubMedCrossRef

29.

Perry PJ, Anderson KH, Yates WR. Illicit anabolic steroid use in athletes: a case series analysis. Am J Sports Med 1990; 18: 422–8PubMedCrossRef

30.

Gill GV. Anabolic steroid induced hypogonadism treated with human chorionic gonadotropin. Postgrad Med J 1998; 74: 45–6PubMedCrossRef

31.

Hervey GR, Knibbs AV, Burkenshaw L, et al. Effects of methandienone on the performance and body composition of men undergoing athletic training. Clin Sci 1981; 60: 457–61PubMed

32.

Duchaine D. Underground steroid handbook II. Venice (CA): HLR Technical Books, 1989

33.

Sader MA, Griffiths KA, McCredie RJ, et al. Androgenic anabolic steroids and arterial structure and function in male bodybuilders. J Am Coll Cardiol 2001; 37: 224–30PubMedCrossRef

34.

Ishak KG, Zimmerman HJ. Hepatotoxic effects of the anabolic/androgenic steroids. Semin Liver Dis 1987; 7: 230–6PubMedCrossRef

35.

Glazer G. Arthrogenic effects of anabolic steroids on serum lipid levels. Arch Intern Med 1991; 151: 1925–33PubMedCrossRef

36.

Koenig H, Goldstone A, Lu CY. Testosterone-mediated sexual dimorphism of the rodent heart: ventricular lysosomes, mitochondria, and cell growth are modulated by androgens. Circulation 1982; 50: 782–7CrossRef

37.

Jarow JP, Lipshultz LI. Anabolic steroid-induced hypogonadotropic hypogonadism. Am J Sports Med 1990; 18: 429–31PubMedCrossRef

38.

MacIndoe JH, Perry PJ, Yates WR, et al. Testosterone suppression of the HPT axis. J Invest Med 1997; 45: 441–7

39.

Holma PK. Effects of an anabolic steroid (metandienone) on spermatogenesis. Contraception 1977; 15: 151–62PubMedCrossRef

40.

Yates WR, Perry PJ, MacIndoe J, et al. Psychosexual effects of three doses of testosterone cycling in normal men. Biol Psychiatry 1999; 45: 254–60PubMedCrossRef

41.

Turek PJ, Williams RH, Gilbauch JH, et al. The reversibility of anabolic steroid-induced azospermia. J Urol 1995; 153: 1628–30PubMedCrossRef

42.

Straus RH, Liggett MT, Lanese RR. Anabolic steroid use and perceived effects in ten weight-trained women athletes. JAMA 1985; 253: 2871–3CrossRef

43.

Conacher GN, Workman DG. Violent crime possibly associated with anabolic steroid use. Am J Psychiatry 1989; 146: 679PubMed

44.

Pope Jr HG, Katz DL. Affective and psychotic symptoms associated with anabolic steroid use. Am J Psychiatry 1988; 145: 487–90PubMed

45.

Seidman SN, Spatz E, Rizzo C, et al. Testosterone replacement therapy of hypogonadal men with major depressive disorder: a randomized, placebo-controlled clinical trial. J Clin Psychiatry 2001; 62: 406–12PubMedCrossRef

46.

Kouri EM, Lukas SE, Pope Jr HG, et al. Increased aggressive responding in male volunteers following the administration of gradually increasing doses of testosterone cypionate. Drug Alcohol Depend 1995; 40: 73–9PubMedCrossRef

47.

Matsumoto AM. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle stimulating hormone, and sperm production. J Clin Endocrinol Metab 1990; 70: 282–7PubMedCrossRef

48.

Pope Jr HG, Kouri EM, Hudson JI. Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial. Arch Gen Psychiatry 2000; 57: 133–40PubMedCrossRef

49.

Su TP, Pagliaro M, Schmidt PJ, et al. Neuropsychiatric effects of anabolic steroids in male normal volunteers. JAMA 1993; 269: 2760–4PubMedCrossRef

50.

Tricker R, Casaburi R, Strorer TW, et al. The effects of supraphysiological doses of testosterone on angry behavior in healthy eugonadal men-a clinical research center study. J Clin Endocrinol Metab 1996; 81: 3754–8PubMedCrossRef

51.

Yates WR, Perry PJ, Murray S. Aggression and hostility in anabolic steroid users. Biol Psychiatry 1992; 31: 1232–4PubMedCrossRef

52.

Pope Jr HG, Katz DL. Psychiatric and medical effects of anabolic- androgenic steroid use. Arch Gen Psychiatry 1994; 51: 375–82PubMedCrossRef

53.

Brower KJ, Blow FC, Young JP, et al. Symptoms and correlates of anabolic-androgenic steroid dependence. Br J Addict 1991; 86: 759–68PubMedCrossRef

54.

Copeland J, Peters R, et al. Anabolic-androgenic steroid use disorder among a sample of Australian competitive and recreational users. Drug Alcohol Depend 2000; 60: 91–6PubMed

Titel: Anabolic Steroids
A Review for the Clinician
verfasst von: Eric C. Kutscher
Brian C. Lund
Paul J. Perry
Publikationsdatum: 01.04.2002
Verlag: Springer International Publishing
Erschienen in: Sports Medicine / Ausgabe 5/2002
Print ISSN: 0112-1642
Elektronische ISSN: 1179-2035
DOI: https://doi.org/10.2165/00007256-200232050-00001

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2002

Dermatologic Disorders of the Athlete

Effect of Dietary Intake on Immune Function in Athletes

Blood Lipids and Lipoproteins in Child and Adolescent Athletes